REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 70 filers reported holding REPARE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $85,658 | -29.9% | 25,957 | 0.0% | 0.00% | – |
| Q1 2024 | $122,257 | -35.5% | 25,957 | 0.0% | 0.00% | -100.0% |
| Q4 2023 | $189,486 | -39.6% | 25,957 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $313,561 | +31.2% | 25,957 | +14.9% | 0.00% | 0.0% |
| Q2 2023 | $239,055 | +7.5% | 22,595 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $222,335 | -33.1% | 22,595 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $332,372 | +142548.9% | 22,595 | +17.9% | 0.00% | 0.0% |
| Q3 2022 | $233 | -99.9% | 19,168 | -0.0% | 0.00% | 0.0% |
| Q2 2022 | $268,000 | +58.6% | 19,170 | +61.9% | 0.00% | – |
| Q1 2022 | $169,000 | -32.4% | 11,837 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $250,000 | -19.6% | 11,837 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $311,000 | -66.6% | 11,837 | -60.5% | 0.00% | -75.0% |
| Q2 2020 | $931,000 | – | 30,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $32,989,176 | 13.80% |
| CHI Advisors LLC | 2,800,126 | $41,189,854 | 10.97% |
| MPM BioImpact LLC | 1,639,849 | $24,122,179 | 6.26% |
| BVF INC/IL | 8,291,988 | $121,975,143 | 5.15% |
| Deep Track Capital, LP | 2,727,606 | $40,123,084 | 1.68% |
| Redmile Group, LLC | 2,684,396 | $39,487,465 | 1.62% |
| HighVista Strategies LLC | 164,890 | $2,425,532 | 1.44% |
| Orbimed Advisors | 3,322,488 | $48,873,798 | 0.94% |
| Artal Group S.A. | 700,000 | $10,297 | 0.58% |
| HARBOR CAPITAL ADVISORS, INC. | 34,572 | $508,554 | 0.49% |